METEOR Trial Reports on the Effect of Rosuvastatin on Progression of Carotid Intima-Media Thickness in Low-Risk Individuals with Subclinical Atherosclerosis.

Authors :: Haddad RM
Ballantyne CM
Source :: The Physician and sportsmedicine [Phys Sportsmed] 2010 Jun; Vol. 38 (2), pp. 180-2.
Publication Year :: 2010
Abstract: Practice Pearl: The data from the METEOR trial show that asymptomatic low-risk patients treated with rosuvastatin have a reduction in progression of carotid intima-media thickness (CIMT) over 2 years versus placebo. ORIGINAL ARTICLE: Crouse JR 3rd, Raichlen JS, Riley WA, et al; METEOR Study Group. Effect of rosuvastatin on progression of carotid intima-media thickness in low-risk individuals with subclinical atherosclerosis: the METEOR Trial. JAMA. 2007;297(12):1344-1353.

Subjects :: Female
Humans
Male
Atherosclerosis drug therapy
Carotid Arteries drug effects
Fluorobenzenes therapeutic use
Hydroxymethylglutaryl-CoA Reductase Inhibitors therapeutic use
Pyrimidines therapeutic use
Sulfonamides therapeutic use
Tunica Intima drug effects

Full Text Access

Tools